Lisa M. Shulman, MD

Lisa M. Shulman MD is a neurologist specializing in Parkinson’s disease and other movement disorders. In addition to neurology, her diverse background includes training in health policy, nursing and education. She is the Eugenia Brin Professor of Parkinson’s Disease and Movement Disorders and the Rosalyn Newman Distinguished Scholar in Parkinson Disease.  Dr. Shulman serves as Treasurer of the American Academy of Neurology and Director of the University of Maryland Movement Disorders Center. She serves on the Board of Directors of both the American Academy of Neurology and the American Brain Foundation.

Dr. Shulman’s major research interest is the impact of chronic neurologic diseases such as Parkinson disease on daily function and quality of life.  Related interests include outcomes measurement, health disparities, exercise interventions, biosensor assessments of mobility, and cognitive/behavioral problems in Parkinson’s and related movement disorders.  She has served as Investigator and Principal Investigator in numerous investigator-initiated and sponsored clinical trials including trials of exercise interventions in Parkinson disease, development of new instruments for measurement of outcomes, and investigation of the genetics of Parkinson disease. Dr. Shulman served as Principal Investigator for the NIH PROMIS Initiative (Patient-reported Outcomes Information System) to develop a new measure of Self-Efficacy for Managing Chronic Conditions. She is currently co-PI on a Seed Grant Challenge to develop innovative quantitative models for data visualization and analysis of big data- complex datasets of health outcomes.

Dr. Shulman is Editor-in-Chief of Neurology Now Books and co-author of the reference book Parkinson’s Disease: A Complete Guide for Patients and Families, now in its third edition and translated in 3 languages.  She is author or editor of 16 books, 30 chapters, 140 peer-reviewed publications and 170 abstracts.

Clinical Practice Special Interests: Management of Parkinson disease and parkinsonism, dystonia, tremor, chorea, tics, myoclonus, gait disorders, tardive dyskinesia, dementia, memory disorders and Botulinum toxin injections for movement disorders, the effects of movement and memory disorders on daily function and quality of life, exercise interventions, gait problems, self-management, self-efficacy, caregiver strain, outcomes research, data visualization and health disparities,Parkinson's Research - Biomarkers, Informatics and Outcomes Visualization

Shulman LM, Armstrong M, Ellis T, Gruber-Baldini A, Horak F, Nieuwboer A, Parashos S, Post B, Rogers M, Siderowf A. Goetz CG, Schrag A, Stebbins GT, Martinez-Martin P, Disability Rating Scales in Parkinson’s Disease- Critique and Recommendations, Movement Disorders 2016.

Parashos SA, Luo S, Biglan KM, Bodis-Wollner I, He B, Liang GS, Ross GW, Tilley BS, Shulman LM for the NET-PD Investigators, Measuring Disease Progression in Early Parkinson Disease, The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. JAMA Neurol. 2014 Jun 1;71(6):710-6.

Shulman LM, Katzel LI, Ivey FM, Sorkin JD, Favors K, Anderson KE, Smith BA, Reich SG, Weiner WJ, Macko RF, Randomized Clinical Trial of Three Types of Physical Training in Parkinson’s Disease, JAMA Neurol. 2013, 70(2):183-90.

Hemming JP, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ and Shulman LM, Racial and Socioeconomic Disparities in Parkinsonism. Arch Neurol, 2011;68(4):498-503.

Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ, What is a Clinically Important Difference on the United Parkinson’s Disease Rating Scale?,  Arch Neurol. 2010;67(1):64-70.

Shulman LM, Gruber-Baldini AL, Anderson KE, Vaughan CG, Reich SG, Fishman PS and Weiner WJ, The Evolution of Disability in Parkinson Disease, Movement Disorders; 2008:23(6):790-796.